These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 20001883)
1. Forget glucose: what about lipids in critical illness? Kruger PS Crit Care Resusc; 2009 Dec; 11(4):305-9. PubMed ID: 20001883 [TBL] [Abstract][Full Text] [Related]
2. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
5. Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. Lind L; Lithell H Clin Intensive Care; 1994; 5(3):100-5. PubMed ID: 10150538 [TBL] [Abstract][Full Text] [Related]
7. [The lipid metabolism of the small intestine and its correlation to the lipid and lipoprotein metabolism of the total organism]. Gangl A Acta Med Austriaca Suppl; 1975; 2():1-49. PubMed ID: 1065179 [TBL] [Abstract][Full Text] [Related]
8. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C; Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528 [TBL] [Abstract][Full Text] [Related]
9. Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care. Price D; Ramachandran S; Knight T; Jones PW; Neary RH Br J Gen Pract; 2000 Sep; 50(458):712-5. PubMed ID: 11050787 [TBL] [Abstract][Full Text] [Related]
10. [Studies of the effects of cis, cis and trans, trans-octadecadienoic acids on lipid metabolism in essential fatty acid deficient rats (author's transl)]. Sano M Hokkaido Igaku Zasshi; 1981 Jan; 56(1):75-87. PubMed ID: 7262821 [TBL] [Abstract][Full Text] [Related]
14. Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients? Drexel H Fundam Clin Pharmacol; 2009 Dec; 23(6):687-92. PubMed ID: 19682084 [TBL] [Abstract][Full Text] [Related]
15. Statins: the next anti-endotoxin. Kruger PS Crit Care Resusc; 2006 Sep; 8(3):223-6. PubMed ID: 16930109 [TBL] [Abstract][Full Text] [Related]
16. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Choy E; Sattar N Ann Rheum Dis; 2009 Apr; 68(4):460-9. PubMed ID: 19286905 [TBL] [Abstract][Full Text] [Related]
17. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Anandh Babu PV; Sabitha KE; Shyamaladevi CS Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499 [TBL] [Abstract][Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. Stanely Mainzen Prince P; Kannan NK J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661 [TBL] [Abstract][Full Text] [Related]